(Q33658043)

28 July 2017

1 reference

title

The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety (English)

1 reference

28 July 2017

0 references

Holsboer F

1

1 reference

28 July 2017

1 May 1999

1 reference

Journal of Psychiatric Research

28 July 2017

1 reference

28 July 2017

33

1 reference

28 July 2017

181-214

1 reference

28 July 2017

3

1 reference

Regulation of pituitary ACTH secretion during chronic stress

28 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Corticotropin releasing factor decreases postburst hyperpolarizations and excites hippocampal neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Hypothalamic control of adrenocorticotropin secretion: advances since the discovery of 41-residue corticotropin-releasing factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Elevated CSF CRF in suicide victims

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

CRF antagonist reverses the "anxiogenic" response to ethanol withdrawal in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Corticotropin-releasing hormone-induced seizures in infant rats originate in the amygdala

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

The CRF1 receptor mediates the excitatory actions of corticotropin releasing factor (CRF) in the developing rat brain: in vivo evidence using a novel, selective, non-peptide CRF receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Endocrine profile and neuroendocrine challenge tests in transgenic mice expressing antisense RNA against the glucocorticoid receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Corticotropin releasing factor binding protein (CRF-BP) is expressed in neuronal and astrocytic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Corticotropin-releasing factor (CRF), CRF-binding protein (CRF-BP), and CRF/CRF-BP complex in Alzheimer's disease and control postmortem human brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

A synaptic model of memory: long-term potentiation in the hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Roles of type I and II corticosteroid receptors in regulation of basal activity in the hypothalamo-pituitary-adrenal axis during the diurnal trough and the peak: evidence for a nonadditive effect of combined receptor occupation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Corticotropin releasing factor (CRF) receptor antagonist blocks activating and 'anxiogenic' actions of CRF in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Corticotropin-releasing factor produces fear-enhancing and behavioral activating effects following infusion into the locus coeruleus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Amitriptyline, desipramine, cyproheptadine and carbamazepine, in concentrations used therapeutically, reduce kainate- and N-methyl-D-aspartate-induced intracellular Ca2+ levels in neuronal culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Maternal care during infancy regulates the development of neural systems mediating the expression of fearfulness in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Corticotrophin-releasing factor receptors: from molecular biology to drug design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Corticotropin-releasing factor immunoreactivity in post-mortem brain from depressed suicides.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Design and synthesis of a series of non-peptide high-affinity human corticotropin-releasing factor1 receptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Expression cloning of a human corticotropin-releasing-factor receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Persistent elevations of cerebrospinal fluid concentrations of corticotropin-releasing factor in adult nonhuman primates exposed to early-life stressors: implications for the pathophysiology of mood and anxiety disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Oxidative stress, glutamate, and neurodegenerative disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Stress update Adaptation of the hypothalamic-pituitary-adrenal axis to chronic stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Identification of two corticotropin-releasing factor receptors from Xenopus laevis with high ligand selectivity: unusual pharmacology of the type 1 receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Mapping of the ligand-selective domain of the Xenopus laevis corticotropin-releasing factor receptor 1: implications for the ligand-binding site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Prenatal stress enhances stress- and corticotropin-releasing factor-induced stimulation of hippocampal acetylcholine release in adult rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Repeated Stress-Induced Activation of Corticotropin-Releasing Factor Neurons Enhances Vasopressin Stores and Colocalization with Corticotropin-Releasing Factor in the Median Eminence of Rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Brain corticosteroid receptor balance in health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Reduced activity of hypothalamic corticotropin-releasing hormone neurons in transgenic mice with impaired glucocorticoid receptor function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Novel mechanism of action for Nur77 and antagonism by glucocorticoids: a convergent mechanism for CRH activation and glucocorticoid repression of POMC gene transcription.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

A molecular and cellular theory of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Corticotropin-releasing factor has an anxiogenic action in the social interaction test.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Effects of corticotropin-releasing factor and growth hormone-releasing factor on sleep and activity in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

7 January 2021

The amygdala and emotion

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Low cerebrospinal fluid corticotropin-releasing hormone concentrations in eucortisolemic depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Psychiatric implications of basic and clinical studies with corticotropin-releasing factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

High intracerebral levels of CRH result in CRH receptor downregulation in the amygdala and neuroimmune desensitization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Regulation of corticotropin-releasing factor receptor function in human Y-79 retinoblastoma cells: rapid and reversible homologous desensitization but prolonged recovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Anti-stress action of a corticotropin-releasing factor antagonist on behavioral reactivity to stressors of varying type and intensity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Learning impairment in transgenic mice with central overexpression of corticotropin-releasing factor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Corticotropin-releasing factor CRF1, but not CRF2, receptors mediate anxiogenic-like behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Prediction of clinical course by dexamethasone suppression test (DST) response in depressed patients - physiological and clinical construct validity of the DST.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Blunted Corticotropin and Normal Cortisol Response to Human Corticotropin-Releasing Factor in Depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

ACTH and multisteroid responses to corticotropin-releasing factor in depressive illness: Relationship to multisteroid responses after ACTH stimulation and dexamethasone suppression☆

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Human corticotropin-releasing hormone in depression--correlation with thyrotropin secretion following thyrotropin-releasing hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression. Implications for pathophysiology of DST nonsuppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Effects of intravenous corticotropin-releasing hormone upon sleep-related growth hormone surge and sleep EEG in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Altered hypothalamic-pituitary-adrenocortical regulation in healthy subjects at high familial risk for affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Sleep deprivation and bright light as potential augmenters of antidepressant drug treatment--neurobiological and psychometric assessment of course.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Rapid stress-induced elevations in corticotropin-releasing hormone mRNA in rat central amygdala nucleus and hypothalamic paraventricular nucleus: an in situ hybridization analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Corticotropin-releasing factor binding sites in cortex of depressed suicides.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Chlordiazepoxide attenuates stress-induced accumulation of corticotropin-releasing factor mRNA in the paraventricular nucleus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Adrenocorticotropin release induced by N-methyl-d-aspartate or stress: mediation by the area postrema.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Glutamate and N-methyl-D-aspartate stimulate rat hypothalamic corticotropin-releasing factor secretion in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Proenkephalin Gene Expression in C6 Rat Glioma Cells: Potentiation of Cyclic Adenosine 3′,5′- Monophosphate-Dependent Transcription by Glucocorticoids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Anna-Monika-Prize paper. Major depression and the environment: a psychiatric genetic perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Stressful life events and genetic liability to major depression: genetic control of exposure to the environment?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

The role of corticotropin-releasing factor in behavioural responses to stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Effect of corticotropin-releasing factor antagonist on behavioral and neuroendocrine responses during exposure to defensive burying paradigm in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Molecular Identification and Analysis of a Novel Human Corticotropin-Releasing Factor (CRF) Receptor: The CRF2 Receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Human amygdala activation during conditioned fear acquisition and extinction: a mixed-trial fMRI study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Persistent changes in corticotropin-releasing factor neuronal systems induced by maternal deprivation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

V1 vasopressin receptor antisense oligodeoxynucleotide into septum reduces vasopressin binding, social discrimination abilities, and anxiety-related behavior in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

The Munich vulnerability study on affective disorders: overview of the cross-sectional observations at index investigation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Cortical concentrations of corticotropin-releasing hormone and its receptor in Alzheimer type dementia and major depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

G protein-coupled receptor kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Chronic infusion of a CRH1 receptor antisense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related behavior in socially defeated rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Behavioural profiles of two Wistar rat lines selectively bred for high or low anxiety-related behaviour.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Differential behavioural effects of chronic infusion of CRH 1 and CRH 2 receptor antisense oligonucleotides into the rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Long-term intracerebroventricular infusion of corticotropin-releasing hormone alters neuroendocrine, neurochemical, autonomic, behavioral, and cytokine responses to a systemic inflammatory challenge.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Augmented pituitary corticotropin response to a threshold dosage of human corticotropin-releasing hormone in depressives pretreated with metyrapone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Maternal care, hippocampal glucocorticoid receptors, and hypothalamic-pituitary-adrenal responses to stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

A non peptidic corticotropin releasing factor receptor antagonist attenuates fever and exhibits anxiolytic-like activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Stress-specific regulation of corticotropin releasing hormone receptor expression in the paraventricular and supraoptic nuclei of the hypothalamus in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Localization of a negative glucocorticoid response element of the human corticotropin releasing hormone gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Antidepressant-like effects of CP-154,526, a selective CRF1 receptor antagonist.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Glutamate receptors in the rat hypothalamus and pituitary.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Involvement of corticotropin-releasing factor in chronic stress regulation of the brain noradrenergic system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Corticotropin releasing factor (CRF)-like immunoreactivity in the rat central nervous system. Extrahypothalamic distribution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Adrenal corticoids regulate sensitivity of noradrenaline receptor-coupled adenylate cyclase in brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Corticosteroid receptor function is decreased in depressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Hormonal response pattern in the combined DEX-CRH test is stable over time in subjects at high familial risk for affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

CSF somatostatin in Alzheimer's disease and major depression: relationship to hypothalamic-pituitary-adrenal axis and clinical measures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Long-term antidepressant treatment reduces behavioural deficits in transgenic mice with impaired glucocorticoid receptor function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Urocortin, a novel neuropeptide with anxiogenic-like properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

cAMP-dependent phosphorylation system after short and long-term administration of moclobemide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

7 January 2021

Steroids and depression

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Chronic antidepressant administration alters the subcellular distribution of cyclic AMP-dependent protein kinase in rat frontal cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Acute effects of alprazolam and adinazolam on the concentrations of corticotropin-releasing factor in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

The neurosteroid tetrahydroprogesterone counteracts corticotropin-releasing hormone-induced anxiety and alters the release and gene expression of corticotropin-releasing hormone in the rat hypothalamus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Effects of excitatory amino acid transmitters on hypothalamic corticotropin-releasing hormone (CRH) and arginine-vasopressin (AVP) release in vitro: implications in pituitary-adrenal regulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Neonatal treatment of rats with the neuroactive steroid tetrahydrodeoxycorticosterone (THDOC) abolishes the behavioral and neuroendocrine consequences of adverse early life events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Antidepressants regulate glucocorticoid receptor messenger RNA concentrations in primary neuronal cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Impaired type II glucocorticoid-receptor function in mice bearing antisense RNA transgene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

cAMP-dependent phosphorylation of soluble and crude microtubule fractions of rat cerebral cortex after prolonged desmethylimipramine treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Glucocorticoid Repression of 3',5'-Cyclic-Adenosine Monophosphate-Dependent Human Corticotropin-Releasing-Hormone Gene Promoter Activity in a Transfected Mouse Anterior Pituitary Cell Line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Cerebrospinal fluid corticotropin-releasing hormone, vasopressin, and oxytocin concentrations in treated patients with major depression and controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

CSF corticotropin-releasing factor (CRF) in Alzheimer's disease: its relationship to severity of dementia and monoamine metabolites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Cloning and characterization of the cDNAs for human and rat corticotropin releasing factor-binding proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

The central distribution of a corticotropin-releasing factor (CRF)-binding protein predicts multiple sites and modes of interaction with CRF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Effects of corticotropin-releasing factor on brain serotonergic activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Regulation of pituitary corticotropin releasing hormone (CRH) receptor mRNA and CRH binding during adrenalectomy: role of glucocorticoids and hypothalamic factors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

New biochemical hypotheses on the mechanism of action of antidepressant drugs: cAMP-dependent phosphorylation system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

DNA binding of the glucocorticoid receptor is not essential for survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Prenatal immune challenge alters the hypothalamic-pituitary-adrenocortical axis in adult rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Hypothalamic-pituitary-adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Unexpected inhibitory action of N-methyl-D,L-aspartate or luteinizing hormone release in adult ovariectomized rhesus monkeys: a role of the hypothalamic-adrenal axis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Resolving GABAA/benzodiazepine receptors: cellular and subcellular localization in the CNS with monoclonal antibodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Immune challenge and immobilization stress induce transcription of the gene encoding the CRF receptor in selective nuclei of the rat hypothalamus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Synthetic Competitive Antagonists of Corticotropin-Releasing Factor: Effect on ACTH Secretion in the Rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Evidence for the involvement of corticotrophin-releasing hormone in the pathogenesis of traumatic brain injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Antidepressants restore hypothalamic-pituitary-adrenal feedback function in aged, cognitively-impaired rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

The corticotropin-releasing hormone stimulation test in patients with panic disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

A microdialysis examination of serotonin release in the rat forebrain induced by behavioral/environmental manipulations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

The neuropsychopharmacological potential of neuroactive steroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Immunohistochemical localization of gamma-aminobutyric acid in the rat pituitary gland and related hypothalamic regions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Identification of a cyclic adenosine monophosphate-responsive element in the rat corticotropin-releasing hormone gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

CP-154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor1 receptor attenuates stress-induced relapse to drug seeking in cocaine- and heroin-trained rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Membrane depolarization and calcium induce c-fos transcription via phosphorylation of transcription factor CREB

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

ICV-CRH alters stress-induced freezing behavior without affecting pain sensitivity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Increase in cortical and midbrain tryptophan hydroxylase activity by intracerebroventricular administration of corticotropin releasing factor: block by adrenalectomy, by RU 38486 and by bilateral lesions to the central nucleus of the amygdala

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Regulation of lordosis behaviour in the female rat by corticotropin-releasing factor, beta-endorphin/corticotropin and luteinizing hormone-releasing hormone neuronal systems in the medial preoptic area.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide induces anxiolytic effects in rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide treatment attenuates social defeat-induced anxiety in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Corticotropin-releasing hormone receptor (type I) antisense targeting reduces anxiety.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Trimipramine and imipramine exert different effects on the sleep EEG and on nocturnal hormone secretion during treatment of major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Appetite-suppressing effects of urocortin, a CRF-related neuropeptide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Identification of a novel murine receptor for corticotropin-releasing hormone expressed in the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Corticotrophin-releasing factor antagonist inhibits neuronal damage induced by focal cerebral ischaemia or activation of NMDA receptors in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Mode of action of antidepressant drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Corticotropin releasing factor produces behavioural activation in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus: a hybridization histochemical study in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Potentiation of acoustic startle by corticotropin-releasing factor (CRF) and by fear are both reversed by alpha-helical CRF (9-41).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Attenuation of stress-induced behavior by antagonism of corticotropin-releasing factor receptors in the central amygdala in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Corticotropin-releasing factor stimulates Ca2+ influx in cultured rat astrocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

A new functional isoform of the human CRF2 receptor for corticotropin-releasing factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-Endorphin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Corticotropin-releasing factor: evidence for a neurotransmitter role in the locus ceruleus during hemodynamic stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

The locus coeruleus as a site for integrating corticotropin-releasing factor and noradrenergic mediation of stress responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Corticotropin-releasing factor-containing axon terminals synapse onto catecholamine dendrites and may presynaptically modulate other afferents in the rostral pole of the nucleus locus coeruleus in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Primary structure and functional expression of mouse pituitary and human brain corticotrophin releasing factor receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Cortisol response to a combined dexamethasone-human corticotrophin-releasing hormone challenge in patients with depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Effect of age on the cortisol response to human corticotropin-releasing hormone in depressed patients pretreated with dexamethasone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Combined administration of human corticotropin-releasing factor and lysine vasopressin induces cortisol escape from dexamethasone suppression in healthy subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Blunting of ACTH response to human CRH in depressed patients is avoided by metyrapone pretreatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Human CRH stimulation response during acute withdrawal and after medium-term abstention from alcohol abuse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

The effect of repeated human corticotropin-releasing hormone administration on dexamethasone-suppressed pituitary-adrenocortical activity in healthy subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Behavioural activation produced by CRH but not alpha-helical CRH (CRH-receptor antagonist) when microinfused into the central nucleus of the amygdala under stress-free conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

The validity of animal models of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Evidence against changes in corticotroph CRF receptors in depressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

Prediction of medium-term outcome by cortisol response to the combined dexamethasone-CRH test in patients with remitted depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

The role of corticotropin-releasing hormone in the pathogenesis of Cushing's disease, anorexia nervosa, alcoholism, affective disorders and dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Phorbol ester and calcium regulation of corticotrophin-releasing factor receptor 1 expression in a neuronal cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2898%2990056-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3956(98)90056-5

1 reference

28 July 2017

1 reference

PubMed ID

10367986